| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:621509 | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:18294627 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CTSB mRNA; more ... | CTD | PMID:20230807 |
| 1-chloro-2,4-dinitrobenzene | increases expression | ISO | RGD:734437 | 6480464 | Dinitrochlorobenzene results in increased expression of CTSB mRNA | CTD | PMID:16314067 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | EXP | | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CTSB mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CTSB mRNA]; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CTSB mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:621509 | 6480464 | Ethinyl Estradiol results in increased expression of CTSB mRNA | CTD | PMID:16140622 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:621509 | 6480464 | Ethinyl Estradiol results in increased expression of CTSB mRNA | CTD | PMID:17557909 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:621509 | 6480464 | Ethinyl Estradiol results in increased expression of CTSB mRNA | CTD | PMID:12655037 more ... |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CTSB mRNA | CTD | PMID:11509743 PMID:15289156 |
| 17beta-estradiol | increases expression | ISO | RGD:734437 | 6480464 | Estradiol results in increased expression of CTSB mRNA; more ... | CTD | PMID:23219593 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CTSB mRNA | CTD | PMID:15289156 PMID:11509743 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | ISO | RGD:734437 | 6480464 | Metribolone results in decreased expression of CTSB protein | CTD | PMID:17152098 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:621509 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CTSB mRNA | CTD | PMID:15644576 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CTSB mRNA | CTD | PMID:21570461 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | decreases activity | ISO | RGD:621509 | 6480464 | Puromycin Aminonucleoside results in decreased activity of CTSB protein | CTD | PMID:10394110 |
| 5-fluorouracil | multiple interactions | ISO | RGD:734437 | 6480464 | CA 074 methyl ester inhibits the reaction [Fluorouracil results in increased cleavage of CTSB protein] | CTD | PMID:19816940 |
| 5-fluorouracil | increases cleavage | ISO | RGD:734437 | 6480464 | Fluorouracil results in increased cleavage of CTSB protein | CTD | PMID:19816940 |
| 6-propyl-2-thiouracil | decreases expression | ISO | RGD:734437 | 6480464 | Propylthiouracil results in decreased expression of CTSB mRNA | CTD | PMID:22342233 |
| 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of CTSB protein | CTD | PMID:18604214 |
| 8'-apo-beta,psi-caroten-8'-al | decreases expression | ISO | RGD:734437 | 6480464 | apocarotenal results in decreased expression of CTSB mRNA | CTD | PMID:17034753 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of CTSB mRNA | CTD | PMID:21353610 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of CTSB mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:734437 | 6480464 | Tretinoin results in increased expression of CTSB mRNA | CTD | PMID:21934132 |
| alprazolam | multiple interactions | ISO | RGD:734437 | 6480464 | [Caffeine co-treated with Alprazolam] results in increased secretion of CTSB protein | CTD | PMID:19490937 |
| ammonium chloride | affects expression | ISO | RGD:621509 | 6480464 | Ammonium Chloride affects the expression of CTSB mRNA | CTD | PMID:16483693 |
| azithromycin | multiple interactions | ISO | RGD:621509 | 6480464 | Cycloheximide inhibits the reaction [Azithromycin results in increased activity of CTSB protein] | CTD | PMID:8830663 |
| azithromycin | increases activity | ISO | RGD:621509 | 6480464 | Azithromycin results in increased activity of CTSB protein | CTD | PMID:8830663 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CTSB mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:734437 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in increased expression of CTSB protein] | CTD | PMID:22138271 |
| benzo[a]pyrene | increases expression | ISO | RGD:734437 | 6480464 | Benzo(a)pyrene results in increased expression of CTSB protein | CTD | PMID:22138271 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CTSB mRNA | CTD | PMID:22228805 |
| beta-carotene | decreases expression | ISO | RGD:734437 | 6480464 | beta Carotene results in decreased expression of CTSB mRNA | CTD | PMID:17034753 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of CTSB mRNA | CTD | PMID:19840844 |
| caffeine | multiple interactions | ISO | RGD:734437 | 6480464 | [Caffeine co-treated with Alprazolam] results in increased secretion of CTSB protein | CTD | PMID:19490937 |
| caffeine | multiple interactions | EXP | | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CTSB mRNA; more ... | CTD | PMID:20230807 |
| calcitriol | increases expression | ISO | RGD:734437 | 6480464 | Calcitriol results in increased expression of CTSB mRNA | CTD | PMID:16847355 PMID:15951637 |
| calcitriol | increases expression | ISO | RGD:734437 | 6480464 | Calcitriol results in increased expression of CTSB mRNA | CTD | PMID:15951637 PMID:16847355 |
| calcitriol | increases expression | ISO | RGD:734437 | 6480464 | Calcitriol results in increased expression of CTSB protein | CTD | PMID:9528999 |
| calcitriol | increases expression | ISO | RGD:734437 | 6480464 | Calcitriol results in increased expression of CTSB | CTD | PMID:8593782 |
| camptothecin | multiple interactions | ISO | RGD:734437 | 6480464 | CTSB protein results in increased cleavage of [Camptothecin analog binds to ALB protein] | CTD | PMID:17378599 |
| chloroacetaldehyde | decreases activity | ISO | RGD:734437 | 6480464 | chloroacetaldehyde results in decreased activity of CTSB protein | CTD | PMID:17035713 |
| chloroquine | increases expression | ISO | RGD:621509 | 6480464 | Chloroquine results in increased expression of CTSB protein | CTD | PMID:2759144 |
| ciprofibrate | increases expression | EXP | | 6480464 | ciprofibrate results in increased expression of CTSB mRNA | CTD | PMID:12771043 |
| cis-caffeic acid | multiple interactions | ISO | RGD:621509 | 6480464 | caffeic acid inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:20391626 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CTSB mRNA | CTD | PMID:21151649 |
| cisplatin | decreases expression | ISO | RGD:621509 | 6480464 | Cisplatin results in decreased expression of CTSB protein | CTD | PMID:22023808 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CTSB mRNA | CTD | PMID:17585979 |
| clofibric acid | multiple interactions | ISO | RGD:621509 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CTSB mRNA | CTD | PMID:17602206 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of CTSB mRNA | CTD | PMID:15681117 |
| cocaine | multiple interactions | EXP | | 6480464 | FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CTSB mRNA] | CTD | PMID:18355967 |
| cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of CTSB mRNA | CTD | PMID:18355967 |
| copper(2+) sulfate | increases expression | ISO | RGD:734437 | 6480464 | Copper Sulfate results in increased expression of CTSB mRNA | CTD | PMID:19549813 |
| coumestrol | decreases expression | ISO | RGD:734437 | 6480464 | Coumestrol results in decreased expression of CTSB mRNA | CTD | PMID:19167446 |
| curcumin | multiple interactions | ISO | RGD:621509 | 6480464 | Curcumin inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:8534267 |
| cycloheximide | multiple interactions | ISO | RGD:621509 | 6480464 | Cycloheximide inhibits the reaction [Azithromycin results in increased activity of CTSB protein] | CTD | PMID:8830663 |
| cyclosporin A | decreases activity | ISO | RGD:734437 | 6480464 | Cyclosporine results in decreased activity of CTSB protein | CTD | PMID:10914799 |
| D-glucose | multiple interactions | ISO | RGD:734437 | 6480464 | Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein] | CTD | PMID:21392095 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CTSB mRNA | CTD | PMID:17178593 |
| diazoxide | decreases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in decreased activity of CTSB protein | CTD | PMID:17188415 |
| diazoxide | multiple interactions | ISO | RGD:621509 | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:18294627 |
| diazoxide | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| diazoxide | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of CTSB mRNA | CTD | PMID:21335049 |
| diazoxide | multiple interactions | ISO | RGD:621509 | 6480464 | caffeic acid inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:20391626 |
| diazoxide | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| diazoxide | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| diazoxide | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:8534267 more ... |
| diazoxide | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:8534267 more ... |
| diazoxide | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| diazoxide | multiple interactions | ISO | RGD:621509 | 6480464 | naringin inhibits the reaction [Isoproterenol results in decreased activity of CTSB protein]; more ... | CTD | PMID:17188415 |
| diazoxide | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:2015110 more ... |
| diazoxide | multiple interactions | ISO | RGD:621509 | 6480464 | Curcumin inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:8534267 |
| dibutyl phthalate | decreases expression | ISO | RGD:621509 | 6480464 | Dibutyl Phthalate results in decreased expression of CTSB mRNA | CTD | PMID:17379624 |
| dibutyl phthalate | increases expression | ISO | RGD:621509 | 6480464 | Dibutyl Phthalate results in increased expression of CTSB mRNA | CTD | PMID:17379624 |
| dichlorine | multiple interactions | ISO | RGD:621509 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CTSB mRNA | CTD | PMID:18636392 |
| diethylstilbestrol | increases activity | ISO | RGD:734437 | 6480464 | Diethylstilbestrol results in increased activity of CTSB protein | CTD | PMID:703988 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CTSB mRNA | CTD | PMID:15289156 |
| dioxygen | multiple interactions | ISO | RGD:734437 | 6480464 | Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein] | CTD | PMID:21392095 |
| diuron | decreases expression | ISO | RGD:621509 | 6480464 | Diuron results in decreased expression of CTSB mRNA | CTD | PMID:21551480 |
| doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of CTSB mRNA | CTD | PMID:19001878 |
| doxorubicin | multiple interactions | EXP | | 6480464 | PARP1 protein promotes the reaction [Doxorubicin results in increased expression of CTSB mRNA] | CTD | PMID:19001878 |
| doxorubicin | multiple interactions | ISO | RGD:734437 | 6480464 | CTSB protein results in increased cleavage of [Doxorubicin analog binds to ALB protein] | CTD | PMID:17378599 |
| doxorubicin | affects expression | ISO | RGD:734437 | 6480464 | Doxorubicin affects the expression of CTSB mRNA | CTD | PMID:16705698 |
| elemental selenium | increases expression | ISO | RGD:734437 | 6480464 | Selenium results in increased expression of CTSB mRNA | CTD | PMID:19244175 |
| ethanol | increases expression | ISO | RGD:621509 | 6480464 | Ethanol results in increased expression of CTSB mRNA | CTD | PMID:7738427 |
| flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of CTSB mRNA | CTD | PMID:11509743 |
| fulvestrant | multiple interactions | ISO | RGD:734437 | 6480464 | fulvestrant inhibits the reaction [4-tert-octylphenol results in increased expression of CTSB mRNA]; more ... | CTD | PMID:23219593 |
| fumonisin B1 | increases expression | EXP | | 6480464 | fumonisin B1 results in increased expression of CTSB mRNA | CTD | PMID:16221962 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CTSB mRNA | CTD | PMID:15289156 |
| glucose | multiple interactions | ISO | RGD:734437 | 6480464 | Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein] | CTD | PMID:21392095 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of CTSB mRNA | CTD | PMID:17178593 |
| hydrogen peroxide | decreases expression | ISO | RGD:621509 | 6480464 | Hydrogen Peroxide results in decreased expression of CTSB protein | CTD | PMID:23178681 |
| hypochlorous acid | decreases expression | EXP | | 6480464 | Hypochlorous Acid results in decreased expression of CTSB mRNA | CTD | PMID:19376150 |
| indomethacin | multiple interactions | ISO | RGD:734437 | 6480464 | Indomethacin inhibits the reaction [CTSB protein results in increased degradation of MBP protein] | CTD | PMID:11071371 |
| indomethacin | decreases activity | ISO | RGD:734437 | 6480464 | Indomethacin results in decreased activity of CTSB protein | CTD | PMID:11071371 |
| isoprenaline | multiple interactions | ISO | RGD:621509 | 6480464 | Curcumin inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:8534267 |
| isoprenaline | multiple interactions | ISO | RGD:621509 | 6480464 | epigallocatechin gallate inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:18294627 |
| isoprenaline | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of CTSB mRNA | CTD | PMID:21335049 |
| isoprenaline | multiple interactions | ISO | RGD:621509 | 6480464 | caffeic acid inhibits the reaction [Isoproterenol results in increased activity of CTSB protein] | CTD | PMID:20391626 |
| isoprenaline | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| isoprenaline | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| isoprenaline | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:17188415 more ... |
| isoprenaline | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:2015110 more ... |
| isoprenaline | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:8534267 more ... |
| isoprenaline | multiple interactions | ISO | RGD:621509 | 6480464 | naringin inhibits the reaction [Isoproterenol results in decreased activity of CTSB protein]; more ... | CTD | PMID:17188415 |
| isoprenaline | increases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in increased activity of CTSB protein | CTD | PMID:8534267 more ... |
| isoprenaline | decreases activity | ISO | RGD:621509 | 6480464 | Isoproterenol results in decreased activity of CTSB protein | CTD | PMID:17188415 |
| L-methionine | multiple interactions | ISO | RGD:734437 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in increased expression of CTSB protein] | CTD | PMID:22138271 |
| LY294002 | multiple interactions | ISO | RGD:734437 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the localization of and results in increased activity of CTSB protein | CTD | PMID:12663669 |
| melatonin | multiple interactions | ISO | RGD:734437 | 6480464 | Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein] | CTD | PMID:21392095 |
| morphine | increases expression | ISO | RGD:621509 | 6480464 | Morphine results in increased expression of CTSB mRNA | CTD | PMID:9429908 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of CTSB mRNA; more ... | CTD | PMID:19840844 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of CTSB mRNA | CTD | PMID:12771043 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621509 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CTSB mRNA | CTD | PMID:17602206 |
| naringin | multiple interactions | ISO | RGD:621509 | 6480464 | naringin inhibits the reaction [Isoproterenol results in decreased activity of CTSB protein]; more ... | CTD | PMID:17188415 |
| nickel sulfate | increases expression | ISO | RGD:734437 | 6480464 | nickel sulfate results in increased expression of CTSB mRNA | CTD | PMID:16314067 |
| okadaic acid | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of CTSB mRNA | CTD | PMID:19840844 |
| ozone | multiple interactions | ISO | RGD:621509 | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of CTSB mRNA | CTD | PMID:18636392 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CTSB mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:734437 | 6480464 | Acetaminophen results in increased expression of CTSB protein | CTD | PMID:22230336 |
| paracetamol | decreases expression | ISO | RGD:734437 | 6480464 | Acetaminophen results in decreased expression of CTSB mRNA | CTD | PMID:21420995 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of CTSB mRNA | CTD | PMID:16797015 |
| phenacetin | increases expression | ISO | RGD:621509 | 6480464 | Phenacetin results in increased expression of CTSB mRNA | CTD | PMID:17698508 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CTSB mRNA | CTD | PMID:23091169 |
| phenylhydrazine | increases expression | ISO | RGD:621509 | 6480464 | phenylhydrazine results in increased expression of CTSB mRNA | CTD | PMID:17698508 |
| phenytoin | increases expression | ISO | RGD:734437 | 6480464 | Phenytoin results in increased expression of CTSB mRNA | CTD | PMID:14741686 |
| phenytoin | decreases activity | ISO | RGD:734437 | 6480464 | Phenytoin results in decreased activity of CTSB protein | CTD | PMID:10914799 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CTSB mRNA | CTD | PMID:19840844 |
| pirinixic acid | multiple interactions | ISO | RGD:734437 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CTSB mRNA | CTD | PMID:19710929 |
| pyrimethamine | increases activity | ISO | RGD:734437 | 6480464 | Pyrimethamine results in increased activity of CTSB protein | CTD | PMID:18593930 |
| quercetin | increases expression | ISO | RGD:734437 | 6480464 | Quercetin results in increased expression of CTSB mRNA | CTD | PMID:21632981 |
| raloxifene | affects expression | ISO | RGD:621509 | 6480464 | Raloxifene affects the expression of CTSB mRNA | CTD | PMID:16079270 |
| retinyl acetate | increases expression | EXP | | 6480464 | retinol acetate results in increased expression of CTSB mRNA | CTD | PMID:16772331 |
| selenium atom | increases expression | ISO | RGD:734437 | 6480464 | Selenium results in increased expression of CTSB mRNA | CTD | PMID:19244175 |
| silicon dioxide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Silicon Dioxide] results in increased secretion of CTSB protein | CTD | PMID:18604214 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTSB mRNA | CTD | PMID:21641980 |
| sulindac | multiple interactions | ISO | RGD:734437 | 6480464 | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of CTSB mRNA] | CTD | PMID:15190207 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of CTSB mRNA | CTD | PMID:17555576 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:734437 | 6480464 | tert-Butylhydroperoxide results in increased expression of CTSB mRNA | CTD | PMID:15336504 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CTSB mRNA | CTD | PMID:17484886 |
| theophylline | increases expression | ISO | RGD:734437 | 6480464 | Theophylline results in increased expression of CTSB mRNA | CTD | PMID:16083514 |
| thioacetamide | increases expression | ISO | RGD:621509 | 6480464 | Thioacetamide results in increased expression of CTSB mRNA | CTD | PMID:16297948 |
| tobramycin | affects activity | ISO | RGD:621509 | 6480464 | Tobramycin affects the activity of CTSB protein | CTD | PMID:6653171 |
| trichloroethene | multiple interactions | EXP | | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of CTSB mRNA] | CTD | PMID:15363585 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CTSB protein | CTD | PMID:18495193 |
| uric acid | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Uric Acid] results in increased secretion of CTSB protein | CTD | PMID:18604214 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CTSB mRNA | CTD | PMID:19136453 |
| zoledronic acid | decreases expression | ISO | RGD:734437 | 6480464 | zoledronic acid results in decreased expression of CTSB protein | CTD | PMID:16475674 |